ArticleInternational journal of pharmaceutics: X2026

A ROS‑responsive liposome for atherosclerosis treatment via combined regulation of lipid metabolism and CD47 blockade.

Peng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.